Skip to main content
. 2021 Jan 6;10(2):172. doi: 10.3390/jcm10020172

Table 1.

Baseline characteristics of patients with and without recurrent nontuberculous mycobacterial pulmonary disease.

Characteristics Non-Recurrent Group (n = 26) Recurrent Group (n = 18) p-Value
Age, y * 58.7 ± 11.8 62.3 ± 10.1 0.55
Sex (male: female)
Height (m) * 1.61 ± 0.09 1.62 ± 0.07 0.73
Weight (kg) * 51.1 ± 8.1 53.7 ± 8.8 0.18
Body mass index (kg/m2) * 19.8 ± 2.6 20.4 ± 2.9 0.12
Pathogen, n (%) 0.74
M. avium complex 16 (61.5) 15 (83.4)
M. abscessus subsp. abscessus 3 (11.5) 1 (5.5)
M. abscessus subsp. massiliense 2 (7.6) 2 (11.1)
Others 3 (11.5)
Mixed pathogen 2 (7.6)
Duration of treatment (days) * 585.5 ± 160.8 683.6 ± 123.3 0.17
CT acquisition to treatment initiation (median, day) 21 14.5 0.42
Treatment termination to CT acquisition (median, day) 21.5 28.2 0.61
Initial CT presentation n (%) 0.76
Nodular bronchiectatic form 14 (53.8) 11 (61.1)
Fibrocavitary form 5 (19.2) 2 (11.1)
Unclassifiable form 7 (26.9) 5 (27.8)

Values are presented as means ± standard deviations or medians (interquartile ranges). Boldface indicates p-values less than 0.05. p-values were obtained using the * Mann–Whitney U test and Fisher’s exact test. CT, computed tomography.

HHS Vulnerability Disclosure